Follow the IMMUNOGEN INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 1 February 2016 (Levée d'options). Among the most active insiders: LAMBERT JOHN. Every trade is free.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
4 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Immunogen Inc is a biopharmaceutical company focused on developing targeted treatments for cancer. It specializes in innovation in antibody-based therapies.